Phase I Study of SYS6043 in Patients With Advanced/Metastatic Solid Tumors
Conjupro Biotherapeutics, Inc.
Conjupro Biotherapeutics, Inc.
Atavistik Bio, Inc
Alterome Therapeutics, Inc.
Baptist Health South Florida
ViroMissile, Inc.
Replimune Inc.
Tizona Therapeutics, Inc
Angiex, Inc.
Iambic Therapeutics, Inc
Novartis
OncoNano Medicine, Inc.
GlaxoSmithKline
AbbVie
AstraZeneca
Rondo Therapeutics
Hummingbird Bioscience
M.D. Anderson Cancer Center
Sanofi
Nurix Therapeutics, Inc.
Exelixis
AbbVie
Cancer Trials Ireland
Boehringer Ingelheim
AbbVie
Williams Cancer Foundation
Tvardi Therapeutics, Incorporated
Zymeworks BC Inc.
Compugen Ltd
NantBioScience, Inc.
Carisma Therapeutics Inc
Jazz Pharmaceuticals
Eli Lilly and Company
Vincerx Pharma, Inc.
Astellas Pharma Inc
Optimal Health Research
Pfizer
GlaxoSmithKline
Pfizer
University of Utah
Lebanese University
National Cancer Institute (NCI)
Pfizer
Multitude Therapeutics Inc.
Lebanese University
M.D. Anderson Cancer Center
Oncorus, Inc.
Quadriga Biosciences, Inc.
Amgen
Daiichi Sankyo
Pfizer